Positron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson's disease and progressive supranuclear palsy.
about
Cholinergic imaging in dementia spectrum disordersFunctional neuroimaging in Parkinson's diseaseNucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer's and Parkinson's diseaseCerebral cortical and subcortical cholinergic deficits in parkinsonian syndromesOlfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's diseaseAn update on brain imaging in parkinsonian dementiaIs synaptic loss a unique hallmark of Alzheimer's disease?Heterogeneity of cholinergic denervation in Parkinson's disease without dementiaNeural Control of Walking in People with Parkinsonism.History of falls in Parkinson disease is associated with reduced cholinergic activityThalamic cholinergic innervation and postural sensory integration function in Parkinson's disease.The cholinergic system and Parkinson disease.Cholinergic dysfunction in Parkinson's disease.Cholinergic depletion and basal forebrain volume in primary progressive aphasia.Parkinson's Disease: What role do pedunculopontine nucleus cholinergic neurons play?Cognitive decline in Parkinson disease.Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects.Syndromic approach to Parkinson's disease: role of functional imaging.Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's disease.Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson's Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage.Neurotransmitter deficits from frontotemporal lobar degeneration.Neuropsychiatric disturbances in atypical parkinsonian disorders
P2860
Q26764933-86D3E2F4-D0EB-4D70-94DD-D1DFD20F639AQ27013767-5F3E9F65-167F-454A-8D02-6D7EF8F25523Q28085513-E8C2B125-2700-4A24-B211-EB1BE813AC4FQ33853330-96E06E52-F0DF-4C80-9E52-F9165F9CFB33Q33882719-5D27C1E7-ABC2-4944-B138-CAA02B6210E4Q34327937-054AB6DA-F07A-4996-B506-7586679955FCQ34504659-207A98BF-9BB9-4E7A-B3A7-CBA05AA3CFDAQ36170361-697A5661-00CF-436C-BC73-CE29E8E35D21Q36956319-64F6828B-8A01-401D-830A-847873B0F6A8Q37459699-338B26BA-9AFE-401D-8B53-072E2A5DB99EQ37511433-439BE5F8-339D-4679-8766-88959E70C58FQ37671065-3A5A191C-5A5F-4912-B2DF-E508215EFB21Q37709932-6405182C-A702-431A-ADCE-200A57E5F739Q38383122-6785FC06-8C17-4329-9EFB-663E91974AD3Q38606300-77103A3C-573C-4B68-BD7B-CB8F3FC8BF18Q38751099-6386B5C0-5E91-4A60-8842-F81D53E63A17Q39303669-DCDC0B38-5E42-4ABE-BCDD-3926E2CCFDAFQ41475217-4DAB9BDD-3CE1-446E-AB2D-8B8C9BD66B50Q41979984-D0EE8A0E-177D-48C9-88E7-A64050D90A8AQ42789671-A3681A5A-EBD5-4961-8AFC-4A574A6519BFQ47824855-C3E473AE-A6C0-4EF1-95BD-ECC5891EA3D1Q47837913-6043E4EE-E782-433C-BBAB-4DB6C4053D79Q57817274-317F14E8-0597-4C7F-B8B5-C4DC0DEEFCA8
P2860
Positron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson's disease and progressive supranuclear palsy.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Positron emission tomographic ...... rogressive supranuclear palsy.
@en
Positron emission tomographic ...... rogressive supranuclear palsy.
@nl
type
label
Positron emission tomographic ...... rogressive supranuclear palsy.
@en
Positron emission tomographic ...... rogressive supranuclear palsy.
@nl
prefLabel
Positron emission tomographic ...... rogressive supranuclear palsy.
@en
Positron emission tomographic ...... rogressive supranuclear palsy.
@nl
P2093
P1433
P1476
Positron emission tomographic ...... rogressive supranuclear palsy.
@en
P2093
Nagatsuka S
Shinotoh H
Yamaguchi M
P356
10.1002/1531-8249(199907)46:1<62::AID-ANA10>3.3.CO;2-G
P577
1999-07-01T00:00:00Z